227 related articles for article (PubMed ID: 34551701)
1. High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.
Deng Y; Liu L; Feng W; Lin Z; Ning Y; Luo X
Recent Pat Anticancer Drug Discov; 2021; 16(4):533-539. PubMed ID: 34551701
[TBL] [Abstract][Full Text] [Related]
2. LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.
Zeng Z; Ji N; Yi J; Lv J; Yuan J; Lin Z; Liu L; Feng X
Cancer Biomark; 2020; 28(1):65-72. PubMed ID: 32176632
[TBL] [Abstract][Full Text] [Related]
3. Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.
Liu L; Lv J; Lin Z; Ning Y; Li J; Liu P; Chen C
Front Mol Biosci; 2021; 8():785922. PubMed ID: 35223984
[No Abstract] [Full Text] [Related]
4. Low expression of KIF7 indicates poor prognosis in epithelial ovarian cancer.
Yao Y; Liu L; He W; Lin X; Zhang X; Lin Z; Zeng Z; Guo S
Cancer Biomark; 2019; 26(4):481-489. PubMed ID: 31658044
[TBL] [Abstract][Full Text] [Related]
5. Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.
Liu L; Hu K; Zeng Z; Xu C; Lv J; Lin Z; Wen B
Recent Pat Anticancer Drug Discov; 2021; 16(1):66-72. PubMed ID: 33573562
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
7. FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.
Liu L; Yi J; Yuan J; Yao T; Lin Z; Ning Y; Zeng Z
Cancer Biomark; 2020; 28(1):1-8. PubMed ID: 32224523
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
10. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
11. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
12. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
[No Abstract] [Full Text] [Related]
13. Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer.
Ning L; Long B; Zhang W; Yu M; Wang S; Cao D; Yang J; Shen K; Huang Y; Lang J
Int J Oncol; 2018 Dec; 53(6):2637-2646. PubMed ID: 30272264
[TBL] [Abstract][Full Text] [Related]
14. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
16. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
Han GH; Yun H; Chung JY; Kim JH; Cho H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
[TBL] [Abstract][Full Text] [Related]
17. MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer.
Liu L; Yi J; Deng X; Yuan J; Zhou B; Lin Z; Zeng Z
Oncol Lett; 2019 Aug; 18(2):1049-1056. PubMed ID: 31423165
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma.
Xu L; Guo Y; Xu N; Chen L; Zhu J; Liu N; Zhang ZY
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023965
[TBL] [Abstract][Full Text] [Related]
20. Tumor Forkhead Box Q1 Is Elevated, Correlates with Increased Tumor Size, International Federation of Gynecology and Obstetrics Stage but Worse Overall Survival in Epithelial Ovarian Cancer Patients.
Wang X; Zhu X
Cancer Biother Radiopharm; 2022 Nov; 37(9):837-842. PubMed ID: 33761267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
